Insulin requirements in patients with diabetes and declining kidney function: differences between insulin analogues and human insulin? - Wikidata - wikimedia - TriplyDB

Insulin requirements in patients with diabetes and declining kidney function: differences between insulin analogues and human insulin?

Insulin requirements in patients with diabetes and declining kidney function: differences between insulin analogues and human insulin?

http://www.wikidata.org/entity/Q37127547

about

Interactions between kidney disease and diabetes: dangerous liaisons Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical Experience Overview of Data Concerning the Safe Use of Antihyperglycemic Medications in Type 2 Diabetes Mellitus and Chronic Kidney Disease.The early effect of sunitinib on insulin clearance in patients with metastatic renal cell carcinoma Treatment with insulin analogs, especially Glargine and Lispro, associates with better renal function and higher hemoglobin levels in Type 1 diabetic patients with impaired kidney function.Current therapeutic approaches in the management of hyperglycemia in chronic renal disease.Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategies.

P2860

Q26740630-97ADC724-7EC3-4481-A22C-FBA5A17EDB24 Q26766259-AA330F2B-CE0D-4AA3-B647-FDED858808FA Q28085428-5739CB5E-B43B-4148-A5FF-7ACEE9B6CFEC Q31025919-3B43FD85-F647-40D3-B475-61AEFD42196D Q36706822-72442B32-77D3-436B-BD05-47221A342CF0 Q37151682-A27998BA-EFED-4266-BE83-7F2AE2F1DDFB Q39160771-D70C0976-2000-40DF-B47E-0A3266CA51D4 Q39350860-5FFB9A6D-CFEC-4E21-B07F-890E28BACDFE

P2860

Insulin requirements in patients with diabetes and declining kidney function: differences between insulin analogues and human insulin?

http://www.wikidata.org/entity/Q37127547

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Insulin requirements in patien ...... n analogues and human insulin?

@en

Insulin requirements in patien ...... n analogues and human insulin?

@nl

type

label

Insulin requirements in patien ...... n analogues and human insulin?

@en

Insulin requirements in patien ...... n analogues and human insulin?

@nl

prefLabel

Insulin requirements in patien ...... n analogues and human insulin?

@en

Insulin requirements in patien ...... n analogues and human insulin?

@nl

P1433

Q37127547-38739744-AEC9-40C5-AF2C-21738CB985AC

P1476

Q37127547-EC630A37-3B9B-499F-B9E7-D0DC5D0004C2

P2093

Q37127547-03E1E236-5BB4-4F8D-B7D4-AD71FB446117

Q37127547-55C01631-EE93-4046-A5D8-20C0BF904916

P2860

Q37127547-04AB6BBE-63D3-471B-8CF5-DDAFE09479F0

Q37127547-0D709002-254B-4528-A56F-55569B699C41

Q37127547-2177BE8A-81D1-4A56-8DD4-F5D90492FC5E

Q37127547-29E0956B-01B3-439E-B4E6-92BC0BB2311A

Q37127547-2F402145-53CA-43DA-84F6-56A469017D23

Q37127547-47D005BD-4480-493B-8E9E-E5F179570C46

Q37127547-5713ADCC-8EED-4AA4-AEC4-4520F20E5C0E

Q37127547-887E70DA-98A4-4011-9F1A-3EAECFE313B9

Q37127547-89CBD825-B77B-4F52-9B0B-75AFBACF60FB

Q37127547-914F7D81-0B3F-4182-A25C-A73082CA7645

P304

Q37127547-D35AE3DC-92EF-443D-8E7C-3EA903BF2915

P31

Q37127547-D535DCB1-2709-4842-9DFA-6CD5C9E5AC54

P356

Q37127547-5B71F30F-F8EC-490D-803A-155D60AC6289

P433

Q37127547-AFE41205-3724-4A1E-8D95-7D22000D06F1

P478

Q37127547-E792D7C2-A8F9-4B95-8032-5667630F6BA6

P577

Q37127547-8D6E7AE4-CA0B-411F-B0FB-1CFA2054D2B6

P698

Q37127547-BB047E9E-36EA-443C-8C04-B3C537BD0CDA

P921

Q37127547-9A064A90-D4B7-471E-8DF6-0BF07D291879

P932

Q37127547-72BF3615-4C69-4E91-9331-DAA9698E2990

P356

2042018813501188

P1433

Therapeutic advances in endocrinology and metabolism

P1476

Insulin requirements in patien ...... n analogues and human insulin?

@en

P2093

Christoph Hasslacher

http://www.w3.org/2001/XMLSchema#string

Felix Kulozik

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Insulin degradation: progress and potential

Clinical pharmacokinetics and pharmacodynamics of insulin aspart.

Pharmacokinetics of insulin aspart in obesity, renal impairment, or hepatic impairment.

Insulin therapy in renal disease.

The renal metabolism of insulin.

Plasma exposure to insulin glargine and its metabolites M1 and M2 after subcutaneous injection of therapeutic and supratherapeutic doses of glargine in subjects with type 1 diabetes.

Severe hypoglycemia and risks of vascular events and death.

Impact of diabetic nephropathy on pharmacodynamic and Pharmacokinetic properties of insulin in type 1 diabetic patients.

A small reduction in glomerular filtration is accompanied by insulin resistance in type I diabetes patients with diabetic nephrophathy.

P304

113-121

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2042018813501188

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23997930

http://www.w3.org/2001/XMLSchema#string

P921

P932

3755527

http://www.w3.org/2001/XMLSchema#string